ArticleMateria socio-medica2024
Seroprevalence of SARS-COV-2 Antibodies Associated with the Use of Personal Protective Equipment in Healthcare Workers.
Article in Materia socio-medica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypothetically, PPE played an estimated influential role in preventing SARS-CoV-2 transmission among HCWs before immune-prophylaxis by vaccination in BH. Objective: This research aims to determine the relationship between PPE use and the serological response to SARS-COV-2 among HCWs. Methods: The sample contained 127 COVID-19 outpatients with an average age of 43.5 ± 10.8, 66% women, and 80 (63%) health workers as the study group (37% non-medical workers as a control subjects). The created questionnaire collected sociodemographic data on comorbidity or not, application of PPE, and severity of the clinical picture of COVID-19 infection. Results: All subjects were monitored for the dynamics of antibodies, separately for IgM- and Ig-G three times, repeated every 3 months (only three before immuno-prophylaxis by vaccinations). A serological investigation of subjects' blood was collected by trained medical staff in vacutainers with a clotting activator to obtain the subjects' serum centrifuged, separated, and tested on the AFIAS 6 COVID-19 apparatus. Healthcare workers who did not wear goggles had significantly higher IgM antibody levels than HCWs who use them [F=9.359 (1, 102), p=.003, partial η2=.084]. Also, HCWs who did not use a visor had significantly higher IgM nucleocapsid antibody titer than those who used it daily or occasionally [F=4.790 (1, 102), p=.031, partial η2=.045]. Increase SARAS-COV-2 IgM titer three, six, or nine months after past COVID-19 infection and before vaccination. Conclusion: It presents a new acute or recent asymptomatic infection in our HCWs and unrecognized COVID-19. This implies considerable source and unrecognized risk of transmission of the SARS-COV-2 virus, and among HCWs, COVID-19 is an infectious disease with a high prevalence rate.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.